Cabotegravir and Etuvetidigene Autotemcel: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Cabotegravir
Etuvetidigene Autotemcel
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of interference with the manufacturing of etuvetidigene autotemcel
Interaction Deep Dive
Anti-retroviral medications may interfere with the manufacturing of etuvetidigene autotemcel. Advise patients not to take anti-retroviral medications for at least one month prior to mobilization until at least 7 days after etuvetidigene autotemcel infusion. If a patient requires anti-retroviral treatment following exposure to HIV/HTLV, delay initiation of etuvetidigene autotemcel treatment until an HIV/HTLV western blot and viral load assay have been performed at 6 months post-exposure1.
Why it happens (mechanism)
Interference with the manufacturing of etuvetidigene autotemcel [HIV-1 derived lentiviral vector (LVV)]
Common questions
Can I take Cabotegravir and Etuvetidigene Autotemcel together?
An increased risk of interference with the manufacturing of etuvetidigene autotemcel Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cabotegravir and Etuvetidigene Autotemcel interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Cabotegravir or Etuvetidigene Autotemcel need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: WASKYRA intravenous injection, etuvetidigene autotemcel intravenous injection. Fondazione Telethon ETS (Per FDA), Rome, Lazio, Italy, 2025. DailyMed
Keep reading about Cabotegravir
Keep reading about Etuvetidigene Autotemcel
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist